Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL (NCT04697940) | Han weidong | 2021-04-15 |
Track Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.